Thanks to our employees’ feedback, we’ve ranked No. 3 on this year’s #WorldsBestWorkplaces list from Great Place To Work US and Fortune. The Ways We Work are part of what drives our culture and business forward. See why we’ve made the list eight years in a row: https://bit.ly/415pqCL #AbbVieLife [Video description: Employees flipping a coin revealing each of the 5 Ways We Work pillars (All For One AbbVie, Decide Smart & Sure, Agile & Accountable, Clear & Courageous, Make Possibilities Real.)]
About us
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- Website
-
http://www.abbvie.com
External link for AbbVie
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- North Chicago, Illinois
- Type
- Public Company
- Specialties
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care
Locations
Employees at AbbVie
Updates
-
Quality is part of all our jobs. Learn more about our approach to quality and safety, supported by our 3,300+ Operations and R&D #QualityAssurance employees, and why we hold ourselves to the highest standards: https://bit.ly/3CnI12h #WorldQualityWeek #WQW24 [Video description: Footage of employees working in labs and having meetings; lab equipment; and a doctor’s visit. On-screen text reads: "At AbbVie, quality is more than just a word – it’s our commitment. Our relentless focus on quality and safety is at the heart of everything we do. When quality comes first, we don’t just deliver medicines, we transform lives."]
-
As we continue to push boundaries in #ADC research, we are honored to be awarded the Best Clinical Publication at this year’s World ADC Event Series in San Diego. Congratulations to the SORAYA clinical team for their research. Learn more about our efforts in cancer research: https://bit.ly/4eqSh7d
-
-
Oyewale Daejin Abidoye, our VP, therapeutic area head, solid tumor, explains the need to improve clinical practices for #biomarker testing in non-small cell lung cancer (#NSCLC). Health care disparities continue to exist in biomarker testing, especially for those in socially disadvantaged communities. Read his latest article to learn more. #LungCancerAwarenessMonth https://lnkd.in/gzg9uFv9
Improving clinical practices for biomarker testing is important to inform treatment approaches for patients with non-small cell lung cancer (#NSCLC), especially for those in underserved communities. Here are my thoughts on the importance of addressing this unmet need. #LungCancerAwarenessMonth #LCAM
-
Hear members of our #Veterans employee resource group discuss their connection to the #VeteransDay theme: legacy to loyalty and service. Learn more about our support for veterans and how they impact our workplace: https://bit.ly/3AFdXPf #BelongAtAbbVie [Video description: Members of the AbbVie Veterans Employee Resource Group share what living with a legacy to loyalty and service means to them.]
-
Genetic medicines have the potential to revolutionize patient care. But how do they work? Learn more in a Q&A with Clark Pan, our VP of biotherapeutics and genetic medicine technologies, and discover how we’re using #GeneticMedicine technologies and platforms to find treatments for patients: https://lnkd.in/g9pUGR7f [Image description: A series of illustrations depicting how genetic medicine works once entered in the body via a vector.]
-
ICYMI: Members of our executive leadership team discussed our Q3 2024 #FinancialResults during this week’s #earnings call. Swipe to learn more about our performance from our leaders. $ABBV [Image description: Members of AbbVie’s executive leadership team share their remarks on our Q3 2024 Financial Results, including: Robert A. Michael, Jeffrey R. Stewart, Carrie Strom, Roopal Thakkar and Scott T. Reents.]
-
The Ways We Work are the five pillars at the foundation of our culture guiding how our employees innovate and collaborate. Throughout October, employees worldwide participated in our annual Celebration of Culture, where they recognized how their individual actions enable us to make a real difference in people’s lives – while also making us a great place to work. Learn more: https://bit.ly/4hsDTOE #AbbVieLife
-
-
Wishing a sincere Shubh Deepavali to all who are celebrating the start of #Diwali, the Festival of Lights. #BelongAtAbbVie [Video description: Imagery showing Diwali celebrations including sparklers, lights and lanterns, and candles.]
-
NEWS: Today we announced a collaboration and option-to-license agreement with EvolveImmune Therapeutics to develop novel multispecific therapeutic antibodies for solid and hematologic malignancies. Learn more: https://bit.ly/4frlfVv #oncology #cancer [Video description: On-screen text reads, "Oncology News."]
Affiliated pages
Similar pages
Browse jobs
Stock
ABBV
NYSE
20 minutes delay
$164.99
-4.64 (-2.735%)
- Open
- 169.63
- Low
- 164.72
- High
- 169.63
Data from Refinitiv
See more info on